Glucagon-like peptide–1 (GLP-1) is a hormone primarily secreted by intestinal L cells and is considered a promising candidate for the treatment of MASLD (7). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.